Showing results (61-70 of 149) with videos related to
Sort By:
Pageof 15
Clinical Pharmacology in Drug Development|June 24, 2025
Disposition and Absolute Bioavailability of Oral Imlunestrant in Healthy Women: A Phase 1, Open-Label StudyAmita Datta-Mannan, Boris Czeskis, Elaine Shanks, et al.Lancet (London, England)|September 5, 2006
Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trialDaina Vanags, Bronwyn Williams, Barbara Johnson, et al.Pharmaceutical Research|July 30, 2024
The Impact of Annealing Methods on the Encapsulating Structure and Storage-Stability of Freeze-Dried Pellets of Probiotic BacteriaShuai Bai Palmkron, Björn Bergenståhl, Stephen Hall, et al.The Journal of Rheumatology|April 17, 2004
A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritisJan Lucas Hoving, Rachelle Buchbinder, Stephen Hall, et al.Journal of the Mechanical Behavior of Biomedical Materials|August 1, 2017
Characterization of the bone-metal implant interface by Digital Volume Correlation of in-situ loading using neutron tomographySophie Le Cann, Erika Tudisco, Christina Perdikouri, et al.Journal of the Science of Food and Agriculture|March 12, 2021
Innovatively processed quinoa (Chenopodium quinoa Willd.) food: chemistry, structure and end-use characteristicsRamune Kuktaite, Ritva Repo-Carrasco-Valencia, Cesar Ch de Mendoza, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthYun-Hee Jeon, Clare Shaw, Stephen Hall, et al.RMD Open|July 25, 2024
Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYONDRonald F van Vollenhoven, Stephen Hall, Alvin F Wells, et al.PLOS Global Public Health|March 24, 2023
Tax abuse-The potential for the Sustainable Development GoalsBernadette A M O'Hare, Marisol J Lopez, Bernadetta Mazimbe, et al.Rheumatology and Therapy|October 18, 2016
Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid ArthritisPeter Nash, Johan Vanhoof, Stephen Hall, et al.Pageof 15